Clari Vest Asset Management LLC Regenxbio Inc. Transaction History

Clari Vest Asset Management LLC

$953 Million
Q2 2024

A detailed history of Clari Vest Asset Management LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 20 shares of RGNX stock, worth $194. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 20 -0.0%

Holding current value

$194

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $609 - $739	-37 Reduced 64.91%	20 $0
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $259,966 - $327,560	-15,088 Reduced 99.62%	57 $1,000
Q1 2023 May 08, 2023	BUY	$18.08 - $24.55 $777 - $1,055	43 Added 0.28%	15,145 $287,000
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $489 - $593	-24 Reduced 0.16%	15,102 $342,000
Q3 2022 Nov 10, 2022	SELL	$22.29 - $35.04 $936 - $1,471	-42 Reduced 0.28%	15,126 $400,000
Q1 2022 May 04, 2022	BUY	$24.62 - $34.31 $143,239 - $199,615	5,818 Added 62.22%	15,168 $504,000
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $18,627 - $24,852	-617 Reduced 6.19%	9,350 $305,000
Q3 2021 Nov 08, 2021	SELL	$29.09 - $45.68 $10,006 - $15,713	-344 Reduced 3.34%	9,967 $418,000
Q2 2021 Aug 09, 2021	BUY	$32.46 - $40.48 $779 - $971	24 Added 0.23%	10,311 $400,000
Q1 2021 May 13, 2021	SELL	$33.61 - $49.95 $20,166 - $29,970	-600 Reduced 5.51%	10,287 $351,000
Q4 2020 Feb 09, 2021	SELL	$26.52 - $49.35 $394,087 - $733,341	-14,860 Reduced 57.72%	10,887 $493,000
Q3 2020 Nov 09, 2020	SELL	$27.01 - $40.26 $31,331 - $46,701	-1,160 Reduced 4.31%	25,747 $709,000
Q2 2020 Aug 12, 2020	SELL	$27.75 - $43.44 $19,896 - $31,146	-717 Reduced 2.6%	26,907 $992,000
Q1 2020 May 04, 2020	BUY	$21.5 - $54.2 $1,225 - $3,089	57 Added 0.21%	27,624 $894,000
Q4 2019 Feb 12, 2020	SELL	$34.54 - $44.87 $633,221 - $822,601	-18,333 Reduced 39.94%	27,567 $1.13 Million
Q3 2019 Nov 12, 2019	SELL	$31.84 - $50.88 $19,104 - $30,528	-600 Reduced 1.29%	45,900 $1.64 Million
Q2 2019 Aug 16, 2019	SELL	$42.0 - $59.29 $12,600 - $17,787	-300 Reduced 0.64%	46,500 $2.39 Million
Q1 2019 May 13, 2019	SELL	$40.82 - $62.45 $137,236 - $209,956	-3,362 Reduced 6.7%	46,800 $2.68 Million
Q4 2018 Feb 05, 2019	BUY	$39.11 - $75.15 $757,990 - $1.46 Million	19,381 Added 62.96%	50,162 $2.1 Million
Q3 2018 Nov 07, 2018	SELL	$65.0 - $82.15 $53,235 - $67,280	-819 Reduced 2.59%	30,781 $2.32 Million
Q2 2018 Aug 10, 2018	BUY	$27.2 - $74.35 $859,520 - $2.35 Million	31,600 New	31,600 $2.26 Million
Q1 2018 May 08, 2018	SELL	$24.05 - $37.5 $796,055 - $1.24 Million	-33,100 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$26.0 - $34.6 $860,600 - $1.15 Million	33,100	33,100 $1.1 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $420M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Account

Clari Vest Asset Management LLC Regenxbio Inc. Transaction History